Vaderis Therapeutics
2 known investors
Vaderis is a biotech company developing therapies for people with hereditary hemorrhagic telangiectasia (HHT) and other rare vascular diseases. It focuses on advancing treatments for patients with unmet medical needs in the rare disease space.
BiotechHealthtech
Investors · 2
Frequently asked questions
- What does Vaderis Therapeutics do?
- Vaderis is a biotech company developing therapies for people with hereditary hemorrhagic telangiectasia (HHT) and other rare vascular diseases. It focuses on advancing treatments for patients with unmet medical needs in the rare disease space.
- Who are Vaderis Therapeutics's investors?
- Vaderis Therapeutics's investors include Droia Ventures, Medicxi.